Bristol-Myers Goes After Celgene

Bristol-Myers to Buy Celgene

Bristol-Myers Squibb is making a $74 billion bet — and investors aren't pleased. The New York-based pharmaceutical giant on Thursday said it would acquire Celgene, a Summit, New Jersey-based cancer drug company, in a cash and stock deal valued at $74 billion...

By | January, 4, 2019|Categories: Articles, Featured|Tags: , , , , , , , |0 Comments

It’s a Rotten AAPL

Apple’s Stock Plunges

Apple had some news for investors to ring in 2019, only it wasn’t good. The company’s revenue this quarter will be significantly lower than it had previously indicated, thanks largely to a slowdown in China sales. Apple’s shares were halted after the stock market closed Wednesday...

By | January, 3, 2019|Categories: Articles, Featured|Tags: , , , , , , , , , , , , |0 Comments

GE: Not Bringing Good Things to Investors

GE Hits New Low

General Electric Co.’s shares continued their long slide Monday even as new Chief Executive Larry Culp tried to put the market at ease about the direction of the conglomerate and its troubled power division. The stock fell as much as 10% Monday before recovering some of its loss to end at $7.99...

By | November, 15, 2018|Categories: Articles, Featured|Tags: , , , , , , , |0 Comments